Clinical Efficacy of Dagliflozin in the Treatment of Type 2 Diabetes Mellitus with Heart Failure and its Effect on In-flammatory Factors and Vascular Endothelial Function

GENG Yao

doi:10.3969/j.issn.1004-5775.2023.05.009

Home>Articles>Clinical Efficacy of Dagliflozin in the Treatment of Type 2 Diabetes Mellitus with Heart Failure and its Effect on In-flammatory Factors and Vascular Endothelial Function

DOI: 10.3969/j.issn.1004-5775.2023.05.009

Clinical Efficacy of Dagliflozin in the Treatment of Type 2 Diabetes Mellitus with Heart Failure and its Effect on In-flammatory Factors and Vascular Endothelial Function

GENG Yao

Machine-generated Keywords：

Publication Date：2023-03-15

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：4( 547-550 )

HEILONG MEDICAL JOURANL

ISSN：1004-5775

Year, Vol.(Issue)：2023,47(5)